These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34046247)

  • 1. Neuroimaging Assessment of Nigrosome 1 with a Multiecho Gre Magnetic Resonance Sequence in the Differentiation Between Parkinsons Disease from Essential Tremor and Healthy Individuals.
    Bienes GHAA; Zorzenon CPF; Alves ED; Tibana LAT; Borges V; Carrete H; Ferraz HB
    Tremor Other Hyperkinet Mov (N Y); 2021 May; 11():17. PubMed ID: 34046247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of nigrosome-1 detection to discriminate patients with Parkinson's disease and essential tremor.
    Perez Akly MS; Stefani CV; Ciancaglini L; Bestoso JS; Funes JA; Bauso DJ; Besada CH
    Neuroradiol J; 2019 Dec; 32(6):395-400. PubMed ID: 31149866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging the Nigrosome 1 in the substantia nigra using susceptibility weighted imaging and quantitative susceptibility mapping: An application to Parkinson's disease.
    Cheng Z; He N; Huang P; Li Y; Tang R; Sethi SK; Ghassaban K; Yerramsetty KK; Palutla VK; Chen S; Yan F; Haacke EM
    Neuroimage Clin; 2020; 25():102103. PubMed ID: 31869769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing Nigrosome-1 Sign Identification via Interpretable AI using True Susceptibility Weighted Imaging.
    Wang C; He N; Zhang Y; Li Y; Huang P; Liu Y; Jin Z; Cheng Z; Liu Y; Wang Y; Zhang C; Haacke EM; Chen S; Yan F; Yang G
    J Magn Reson Imaging; 2024 Nov; 60(5):1904-1915. PubMed ID: 38236577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of nigrosome 1 in substantia nigra at 3T using multiecho susceptibility map-weighted imaging (SMWI).
    Nam Y; Gho SM; Kim DH; Kim EY; Lee J
    J Magn Reson Imaging; 2017 Aug; 46(2):528-536. PubMed ID: 27859983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic resonance imaging evaluation of nigrosome 1 and neuromelanin can assist Parkinson's disease diagnosis, but requires an expert neuroradiologist.
    De Pietro Franco Zorzenon C; Almeida Antônio Bienes GH; Duarte Alves E; Tobaru Tibana LA; Carrete Júnior H; Ballalai Ferraz H
    Parkinsonism Relat Disord; 2021 Feb; 83():8-12. PubMed ID: 33418131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 'swallow tail' appearance of the healthy nigrosome - a new accurate test of Parkinson's disease: a case-control and retrospective cross-sectional MRI study at 3T.
    Schwarz ST; Afzal M; Morgan PS; Bajaj N; Gowland PA; Auer DP
    PLoS One; 2014; 9(4):e93814. PubMed ID: 24710392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease related signal change in the nigrosomes 1-5 and the substantia nigra using T2* weighted 7T MRI.
    Schwarz ST; Mougin O; Xing Y; Blazejewska A; Bajaj N; Auer DP; Gowland P
    Neuroimage Clin; 2018; 19():683-689. PubMed ID: 29872633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simple quantitative planimetric measurement of nigrosome-1 for clinical settings.
    Chau MT; Agzarian M; Wilcox RA; Dwyer A; Bezak E; Todd G
    J Neurol Sci; 2023 Nov; 454():120857. PubMed ID: 37939625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization of nigrosome 1 and its loss in PD: pathoanatomical correlation and in vivo 7 T MRI.
    Blazejewska AI; Schwarz ST; Pitiot A; Stephenson MC; Lowe J; Bajaj N; Bowtell RW; Auer DP; Gowland PA
    Neurology; 2013 Aug; 81(6):534-40. PubMed ID: 23843466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromelanin-sensitive MRI of the substantia nigra: An imaging biomarker to differentiate essential tremor from tremor-dominant Parkinson's disease.
    Wang J; Huang Z; Li Y; Ye F; Wang C; Zhang Y; Cheng X; Fei G; Liu K; Zeng M; Zhong C; Jin L
    Parkinsonism Relat Disord; 2019 Jan; 58():3-8. PubMed ID: 30037690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nigrosome-1 on Susceptibility Weighted Imaging to Differentiate Parkinson's Disease From Atypical Parkinsonism: An In Vivo and Ex Vivo Pilot Study.
    Meijer FJ; Steens SC; van Rumund A; van Cappellen van Walsum AM; Küsters B; Esselink RA; Verbeek MM; Bloem BR; Goraj B
    Pol J Radiol; 2016; 81():363-9. PubMed ID: 27559425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transcranial sonography (TCS) in evaluation of patients with essential tremor].
    Budisić M; Trkanjec Z; Lovrencić-Huzjan A; Supanc V; Vuković V; Demarin V
    Acta Med Croatica; 2009 Dec; 63 Suppl 3():51-4. PubMed ID: 20232670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.
    Reimão S; Pita Lobo P; Neutel D; Guedes LC; Coelho M; Rosa MM; Azevedo P; Ferreira J; Abreu D; Gonçalves N; Nunes RG; Campos J; Ferreira JJ
    Mov Disord; 2015 Jun; 30(7):953-9. PubMed ID: 25758364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substantia nigra hyperechogenicity in essential tremor and Parkinson's disease: a longitudinal study.
    Cardaioli G; Ripandelli F; Paolini Paoletti F; Nigro P; Simoni S; Brahimi E; Romoli M; Filidei M; Eusebi P; Calabresi P; Tambasco N
    Eur J Neurol; 2019 Nov; 26(11):1370-1376. PubMed ID: 31094036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential diagnosis of tremor syndromes using MRI relaxometry.
    Filip P; Vojtíšek L; Baláž M; Mangia S; Michaeli S; Šumec R; Bareš M
    Parkinsonism Relat Disord; 2020 Dec; 81():190-193. PubMed ID: 33186797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined Visualization of Nigrosome-1 and Neuromelanin in the Substantia Nigra Using 3T MRI for the Differential Diagnosis of Essential Tremor and
    Jin L; Wang J; Wang C; Lian D; Zhou Y; Zhang Y; Lv M; Li Y; Huang Z; Cheng X; Fei G; Liu K; Zeng M; Zhong C
    Front Neurol; 2019; 10():100. PubMed ID: 30809189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A preliminary attempt to visualize nigrosome 1 in the substantia nigra for Parkinson's disease at 3T: An efficient susceptibility map-weighted imaging (SMWI) with quantitative susceptibility mapping using deep neural network (QSMnet).
    Jo M; Oh SH
    Med Phys; 2020 Mar; 47(3):1151-1160. PubMed ID: 31883389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical MR imaging in Parkinson's disease: How useful is the swallow tail sign?
    Prasuhn J; Neumann A; Strautz R; Dreischmeier S; Lemmer F; Hanssen H; Heldmann M; Schramm P; Brüggemann N
    Brain Behav; 2021 Jul; 11(7):e02202. PubMed ID: 34032020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing Parkinson's disease by combining neuromelanin and iron imaging features using an automated midbrain template approach.
    Jokar M; Jin Z; Huang P; Wang Y; Zhang Y; Li Y; Cheng Z; Liu Y; Tang R; Shi X; Min J; Liu F; Chen S; He N; Haacke EM; Yan F
    Neuroimage; 2023 Feb; 266():119814. PubMed ID: 36528314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.